A detailed history of Ruedi Wealth Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ruedi Wealth Management, Inc. holds 19 shares of AMGN stock, worth $5,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 30 36.67%
Holding current value
$5,508
Previous $9.37 Million 34.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$309.38 - $337.38 $3,403 - $3,711
-11 Reduced 36.67%
19 $6.12 Million
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $2,890 - $3,512
11 Added 57.89%
30 $9.37 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $4,858 - $5,480
19 New
19 $5.47 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $5,870 - $7,155
-26 Reduced 25.49%
76 $18.4 Million
Q4 2022

Feb 21, 2023

BUY
$229.03 - $291.01 $23,361 - $29,683
102 New
102 $26.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ruedi Wealth Management, Inc. Portfolio

Follow Ruedi Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruedi Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ruedi Wealth Management, Inc. with notifications on news.